PTC Therapeutics, Inc. ( PTCT) - Key Metrics
PTCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.34 | $1.01 | $1.56 | $1.47 |
| 2026Q1 | $3.30 | -$0.03 | -$0.72 | -$0.73 |
| 2025Q4 | $2.04 | -$1.67 | -$0.42 | -$0.89 |
| 2025Q3 | $2.59 | $0.20 | -$0.81 | -$3.96 |
| 2025Q2 | $2.29 | -$0.83 | -$0.75 | -$0.80 |
PTCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 20.19 |
| 2026Q1 | 0% | -567.75 |
| 2025Q4 | 0% | -11.37 |
| 2025Q3 | 0% | 76.71 |
| 2025Q2 | 0% | -14.71 |
PTCT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.80% | 0% |
| 2026Q1 | -1.07% | 0% |
| 2025Q4 | -1.17% | 0% |
| 2025Q3 | -6.45% | 0% |
| 2025Q2 | -1.63% | 0% |
PTCT
Price: $71.70
52 week price:
Earnings Per Share: -0.67 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 588300
Ebitda: -20.6 millionMarket Capitalization: 5.9 billion